DCDQ

Overview

DCDQ is a potent acetylcholinesterase ( AChE ) inhibitor. DCDQ shows a strong binding affinity with the 4EY7 protein (binding energy: −8.2 kcal/mol). DCDQ is promising for research of Alzheimer's disease (AD).

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Cholinesterase (ChE)

Product Information

• Catalog No.: HY-170811
• CAS No.: 27631-29-4
• Molecular Formula: C10H8Cl2N2O2
• Molecular Weight: 259.09
• Purity: 99.94%
• Storage: -20°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 1.67 mg/mL (6.45 mM); Clear solution
• Availability: In-stock

Source

Original product source